Name: Phage Therapy - Part a (Volume 200) (Progress in Molecular Biology and Translational Science, Volume 200) (en Inglés)
Price: 141740.00 CLP
Availability: InStock
Author: Singh Vijai
ISBN: 9780323955638

portada Phage Therapy - Part a (Volume 200) (Progress in Molecular Biology and Translational Science, Volume 200) (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Singh Vijai

Idioma

Inglés

N° páginas

300

Encuadernación

Tapa Dura

ISBN13

9780323955638

N° edición

Phage Therapy - Part a (Volume 200) (Progress in Molecular Biology and Translational Science, Volume 200) (en Inglés)

Singh Vijai (Autor) · Academic Press · Tapa Dura

Libro Físico

$ 141.740

$ 257.700

Ahorras: $ 115.960

45% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 16 de Julio y el Viernes 26 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Phage Therapy - Part a (Volume 200) (Progress in Molecular Biology and Translational Science, Volume 200) (en Inglés)"

Phage Therapy - Part A, Volume 200 is an informative text on phage and their use for treatment in bacterial infections. The book highlights a number of aspects of the phage in a way that can help students, researchers, clinicians, entrepreneurs and stakeholders perform their research with great interest. Chapters in this new release cover An introduction to bacteriophage and their therapeutic applications, Isolation, screening and characterization of phage, Synthetic phage and their application in phage therapy, Phage engineering for development of diagnostic tools, Phage design and directed evolution to evolve phage for therapy, and more. Additional sections cover Host-phage interactions and modelling for therapy, Phage and phage cocktails formulations, Phage for treatment of Escherichia coli infection, Phage for treatment of Klebsiella pneumoniae infection, Phage for treatment of Salmonella spp infection, Phage for treatment of Staphylococcus aureus infection, and Phages for treatment of Acinetobacter baumannii infection.